Estrogen treatment of postmenopausal women is effective in relieving the symptoms of vasomotor instability and urogenital atrophy; estrogen treatment is effective in preventing accelerated bone loss and osteoporosis in young women following castration, but in postmenopausal women aging is a more important determinant of accelerated bone loss than is decreased estrogen secretion. Low-dose estrogen treatment of postmenopausal women neither prevents nor increases the risk of arteriosclerotic cardiovascular disease or cerebral vascular disease. It cannot be definitively established that estrogen treatment of postmenopausal women causes an increased incidence of breast tumors, but it is clear that such treatment does not prevent these tumors. It is established that estrogen treatment of postmenopausal women increases the risk ratio of endometrial carcinoma.
(JAMA 238:1524-1530, 1977)
Shoemaker ES, Forney JP, MacDonald PC. Estrogen Treatment of Postmenopausal WomenBenefits and Risks. JAMA. 1977;238(14):1524–1530. doi:10.1001/jama.1977.03280150094037
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: